The DOI matches its Crossref record; 161 of the 161 references it cites were found in a registry or an index.
An update on drugs with therapeutic potential for SARS-CoV-2 (COVID-19) treatment
Open accessAbstract
The COVID-19 pandemic is one of the greatest threats to human health in the 21st century with more than 257 million cases and over 5.17 million deaths reported worldwide (as of November 23, 2021. Various agents were initially proclaimed to be effective against SARS-CoV-2, the etiological agent of COVID-19. Hydroxychloroquine, lopinavir/ritonavir, and ribavirin are all examples of therapeutic agents, whose efficacy against COVID-19 was later disproved. Meanwhile, concentrated efforts of researchers and clinicians worldwide have led to the identification of novel therapeutic options to control the disease including PAXLOVID™ (PF-07321332). Although COVID-19 cases are currently treated using a comprehensive approach of anticoagulants, oxygen, and antibiotics, the novel Pfizer agent PAXLOVID™ (PF-07321332), an investigational COVID-19 oral antiviral candidate, significantly reduced hospitalization time and death rates, based on an interim analysis of the phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 in High-Risk Patients) randomized, double-blind study of non-hospitalized adult patients with COVID-19, who are at high risk of progressing to severe illness. The scheduled interim analysis demonstrated an 89% reduction in risk of COVID-19-related hospitalization or death from any cause compared to placebo in patients treated within three days of symptom onset (primary endpoint). However, there still exists a great need for the development of additional treatments, as the recommended therapeutic options are insufficient in many cases. Thus far, mRNA and vector vaccines appear to be the most effective modalities to control the pandemic. In the current review, we provide an update on the progress that has been made since April 2020 in clinical trials concerning the effectiveness of therapies available to combat COVID-19. We focus on currently recommended therapeutic agents, including steroids, various monoclonal antibodies, remdesivir, baricitinib, anticoagulants and PAXLOVID™ summarizing the latest original studies and meta-analyses. Moreover, we aim to discuss other currently and previously studied agents targeting COVID-19 that either show no or only limited therapeutic activity. The results of recent studies report that hydroxychloroquine and convalescent plasma demonstrate no efficacy against SARS-CoV-2 infection. Lastly, we summarize the studies on various drugs with incoherent or insufficient data concerning their effectiveness, such as amantadine, ivermectin, or niclosamide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zaidi, A. K., & Dehgani‐Mobaraki, P. (2021) · The Journal of Antibiotics · doi:10.1038/s41429-021-00430-5 · Cited by 40
RetractedClinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Origin and evolution of pathogenic coronaviruses
Cui, J., Li, F., & Shi, Z.-L. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0118-9 · Cited by 5,515
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787
Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant
Lopez Bernal, J., Andrews, N., Gower, C., Gallagher, E., Simmons, R., Thelwall, S., Stowe, J., Tessier, E., Groves, N., Dabrera, G., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2108891 · Cited by 2,889
Summary of product characteristics
(2013) · Pharmaceutical Medicine · doi:10.1093/med/9780199609147.003.0027 · Cited by 1,905
Coronaviruses post-SARS: update on replication and pathogenesis
Perlman, S., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,764
Long covid—mechanisms, risk factors, and management
Crook, H., Raza, S., Nowell, J., Young, M., & Edison, P. (2021) · BMJ · doi:10.1136/bmj.n1648 · Cited by 1,655
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
Weinreich, D. M., Sivapalasingam, S., Norton, T., Ali, S., Gao, H., Bhore, R., Musser, B. J., Soo, Y., Rofail, D., Im, J., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2035002 · Cited by 1,642
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Goldman, J. D., Lye, D. C. B., Hui, D. S., Marks, K. M., Bruno, R., Montejano, R., Spinner, C. D., Galli, M., Ahn, M.-Y., Nahass, R. G., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2015301 · Cited by 1,362
Spinner, C. D., Gottlieb, R. L., Criner, G. J., Arribas López, J. R., Cattelan, A. M., Soriano Viladomiu, A., Ogbuagu, O., Malhotra, P., Mullane, K. M., Castagna, A., et al. (2020) · JAMA · doi:10.1001/jama.2020.16349 · Cited by 1,211
Tang, W., Cao, Z., Han, M., Wang, Z., Chen, J., Sun, W., Wu, Y., Xiao, W., Liu, S., Chen, E., et al. (2020) · BMJ · doi:10.1136/bmj.m1849 · Cited by 1,135
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Rosas, I. O., Bräu, N., Waters, M., Go, R. C., Hunter, B. D., Bhagani, S., Skiest, D., Aziz, M. S., Cooper, N., Douglas, I. S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2028700 · Cited by 1,125
Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab
Gupta, A., Gonzalez-Rojas, Y., Juarez, E., Crespo Casal, M., Moya, J., Falci, D. R., Sarkis, E., Solis, J., Zheng, H., Scott, N., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2107934 · Cited by 1,086
Waning Immunity after the BNT162b2 Vaccine in Israel
Goldberg, Y., Mandel, M., Bar-On, Y. M., Bodenheimer, O., Freedman, L., Haas, E. J., Milo, R., Alroy-Preis, S., Ash, N., & Huppert, A. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2114228 · Cited by 1,034
Endoplasmic reticulum stress signalling-from basic mechanisms to clinical applications
Almanza, A., Carlesso, A., Chintha, C., Creedican, S., Doultsinos, D., Leuzzi, B., Luís, A., McCarthy, N., Montibeller, L., More, S., et al. (2019) · The FEBS Journal · doi:10.1111/febs.14608 · Cited by 1,034
Bhimraj, A., Morgan, R. L., Shumaker, A. H., Lavergne, V., Baden, L., Cheng, V. C.-C., Edwards, K. M., Gandhi, R., Muller, W. J., O’Horo, J. C., et al. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa478 · Cited by 1,033
Colchicine—Update on mechanisms of action and therapeutic uses
Leung, Y. Y., Yao Hui, L. L., & Kraus, V. B. (2015) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2015.06.013 · Cited by 950
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock
Marik, P. E., Khangoora, V., Rivera, R., Hooper, M. H., & Catravas, J. (2017) · Chest · doi:10.1016/j.chest.2016.11.036 · Cited by 887
Gottlieb, R. L., Nirula, A., Chen, P., Boscia, J., Heller, B., Morris, J., Huhn, G., Cardona, J., Mocherla, B., Stosor, V., et al. (2021) · JAMA · doi:10.1001/jama.2021.0202 · Cited by 872
Favipiravir versus Arbidol for COVID-19: A Randomized Clinical Trial
Chen, C., Zhang, Y., Huang, J., Yin, P., Cheng, Z., Wu, J., Chen, S., Zhang, Y., Chen, B., Lu, M., et al. (2020) · doi:10.1101/2020.03.17.20037432 · Cited by 852
Chen, C., Zhang, Y., Huang, J., Yin, P., Cheng, Z., Wu, J., Chen, S., Zhang, Y., Chen, B., Lu, M., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.683296 · Cited by 849
The Science Underlying COVID-19: Implications for the Cardiovascular System
Liu, P. P., Blet, A., Smyth, D., & Li, H. (2020) · Circulation · doi:10.1161/circulationaha.120.047549 · Cited by 800
Marconi, V. C., Ramanan, A. V., de Bono, S., Kartman, C. E., Krishnan, V., Liao, R., Piruzeli, M. L. B., Goldman, J. D., Alatorre-Alexander, J., de Cassia Pellegrini, R., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00331-3 · Cited by 695
Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 “long haulers”
Graham, E. L., Clark, J. R., Orban, Z. S., Lim, P. H., Szymanski, A. L., Taylor, C., DiBiase, R. M., Jia, D. T., Balabanov, R., Ho, S. U., et al. (2021) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51350 · Cited by 693
Wagstaff, K. M., Sivakumaran, H., Heaton, S. M., Harrich, D., & Jans, D. A. (2012) · Biochemical Journal · doi:10.1042/bj20120150 · Cited by 680
Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19
Dougan, M., Nirula, A., Azizad, M., Mocherla, B., Gottlieb, R. L., Chen, P., Hebert, C., Perry, R., Boscia, J., Heller, B., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2102685 · Cited by 663
A systematic review of the use of opioids in the management of dyspnoea
Jennings, A.-L. (2002) · Thorax · doi:10.1136/thorax.57.11.939 · Cited by 644
Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19)
Aleem, A., Samad, A., & Slenker, A. K. (2021) · Europe PMC (PubMed Central) · Cited by 591
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates
Jones, B. E., Brown-Augsburger, P. L., Corbett, K. S., Westendorf, K., Davies, J., Cujec, T. P., Wiethoff, C. M., Blackbourne, J. L., Heinz, B. A., Foster, D., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abf1906 · Cited by 573
Wang, Z., Chen, X., Lu, Y., Chen, F., & Zhang, W. (2020) · BioScience Trends · doi:10.5582/bst.2020.01030 · Cited by 544
Fischer, W. A., Eron, J. J., Holman, W., Cohen, M. S., Fang, L., Szewczyk, L. J., Sheahan, T. P., Baric, R., Mollan, K. R., Wolfe, C. R., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl7430 · Cited by 529
Pun, B. T., Badenes, R., Heras La Calle, G., Orun, O. M., Chen, W., Raman, R., Simpson, B.-G. K., Wilson-Linville, S., Hinojal Olmedillo, B., Vallejo de la Cueva, A., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30552-x · Cited by 522
SARS-CoV-2 variants and ending the COVID-19 pandemic
Fontanet, A., Autran, B., Lina, B., Kieny, M. P., Karim, S. S. A., & Sridhar, D. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00370-6 · Cited by 519
The COVID-19 pandemic: a global health crisis
Pollard, C. A., Morran, M. P., & Nestor-Kalinoski, A. L. (2020) · Physiological Genomics · doi:10.1152/physiolgenomics.00089.2020 · Cited by 514
COVID-19: ICU delirium management during SARS-CoV-2 pandemic
Kotfis, K., Williams Roberson, S., Wilson, J. E., Dabrowski, W., Pun, B. T., & Ely, E. W. (2020) · Critical Care · doi:10.1186/s13054-020-02882-x · Cited by 506
Self-citationLenze, E. J., Mattar, C., Zorumski, C. F., Stevens, A., Schweiger, J., Nicol, G. E., Miller, J. P., Yang, L., Yingling, M., Avidan, M. S., et al. (2020) · JAMA · doi:10.1001/jama.2020.22760 · Cited by 495
Zinc is an Antioxidant and Anti-Inflammatory Agent: Its Role in Human Health
Prasad, A. S. (2014) · Frontiers in Nutrition · doi:10.3389/fnut.2014.00014 · Cited by 489
Zhang, X.-J., Qin, J.-J., Cheng, X., Shen, L., Zhao, Y.-C., Yuan, Y., Lei, F., Chen, M.-M., Yang, H., Bai, L., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.06.015 · Cited by 474
Modulation of the Immune Response to Respiratory Viruses by Vitamin D
Greiller, C., & Martineau, A. (2015) · Nutrients · doi:10.3390/nu7064240 · Cited by 469
Monk, P. D., Marsden, R. J., Tear, V. J., Brookes, J., Batten, T. N., Mankowski, M., Gabbay, F. J., Davies, D. E., Holgate, S. T., Ho, L.-P., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30511-7 · Cited by 438
Silva Andrade, B., Siqueira, S., de Assis Soares, W. R., de Souza Rangel, F., Santos, N. O., dos Santos Freitas, A., Ribeiro da Silveira, P., Tiwari, S., Alzahrani, K. J., Góes-Neto, A., et al. (2021) · Viruses · doi:10.3390/v13040700 · Cited by 435
Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia
Guimarães, P. O., Quirk, D., Furtado, R. H., Maia, L. N., Saraiva, J. F., Antunes, M. O., Kalil Filho, R., Junior, V. M., Soeiro, A. M., Tognon, A. P., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2101643 · Cited by 435
Barros-Martins, J., Hammerschmidt, S. I., Cossmann, A., Odak, I., Stankov, M. V., Morillas Ramos, G., Dopfer-Jablonka, A., Heidemann, A., Ritter, C., Friedrichsen, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01449-9 · Cited by 425
Covid-19: Pfizer’s paxlovid is 89% effective in patients at risk of serious illness, company reports
Mahase, E. (2021) · BMJ · doi:10.1136/bmj.n2713 · Cited by 421
The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review
González Canga, A., Sahagún Prieto, A. M., Diez Liébana, M. J., Fernández Martínez, N., Sierra Vega, M., & García Vieitez, J. J. (2008) · The AAPS Journal · doi:10.1208/s12248-007-9000-9 · Cited by 419
Self, W. H., Semler, M. W., Leither, L. M., Casey, J. D., Angus, D. C., Brower, R. G., Chang, S. Y., Collins, S. P., Eppensteiner, J. C., Filbin, M. R., et al. (2020) · JAMA · doi:10.1001/jama.2020.22240 · Cited by 417
Ramakrishnan, S., Nicolau, D. V., Langford, B., Mahdi, M., Jeffers, H., Mwasuku, C., Krassowska, K., Fox, R., Binnian, I., Glover, V., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00160-0 · Cited by 416
Shi, C.-S., Nabar, N. R., Huang, N.-N., & Kehrl, J. H. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0181-7 · Cited by 404
Jin, Y., Ji, W., Yang, H., Chen, S., Zhang, W., & Duan, G. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00454-7 · Cited by 399
Painter, W. P., Holman, W., Bush, J. A., Almazedi, F., Malik, H., Eraut, N. C. J. E., Morin, M. J., Szewczyk, L. J., & Painter, G. R. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02428-20 · Cited by 397
Choi, A., Koch, M., Wu, K., Chu, L., Ma, L., Hill, A., Nunna, N., Huang, W., Oestreicher, J., Colpitts, T., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01527-y · Cited by 396
Respiratory follow-up of patients with COVID-19 pneumonia
George, P. M., Barratt, S. L., Condliffe, R., Desai, S. R., Devaraj, A., Forrest, I., Gibbons, M. A., Hart, N., Jenkins, R. G., McAuley, D. F., et al. (2020) · Thorax · doi:10.1136/thoraxjnl-2020-215314 · Cited by 390
SARS-CoV-2 Neutralization with BNT162b2 Vaccine Dose 3
Falsey, A. R., Frenck, R. W., Walsh, E. E., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Bailey, R., Swanson, K. A., Xu, X., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2113468 · Cited by 361
Datta, S. D., Talwar, A., & Lee, J. T. (2020) · JAMA · doi:10.1001/jama.2020.22717 · Cited by 316
Chow, J. H., Khanna, A. K., Kethireddy, S., Yamane, D., Levine, A., Jackson, A. M., McCurdy, M. T., Tabatabai, A., Kumar, G., Park, P., et al. (2021) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005292 · Cited by 309
Davoudi-Monfared, E., Rahmani, H., Khalili, H., Hajiabdolbaghi, M., Salehi, M., Abbasian, L., Kazemzadeh, H., & Yekaninejad, M. S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01061-20 · Cited by 306
Kirtipal, N., Bharadwaj, S., & Kang, S. G. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104502 · Cited by 306
Axfors, C., Schmitt, A. M., Janiaud, P., van’t Hooft, J., Abd-Elsalam, S., Abdo, E. F., Abella, B. S., Akram, J., Amaravadi, R. K., Angus, D. C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22446-z · Cited by 295
Hombach-Klonisch, S., Mehrpour, M., Shojaei, S., Harlos, C., Pitz, M., Hamai, A., Siemianowicz, K., Likus, W., Wiechec, E., Toyota, B. D., et al. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.10.017 · Cited by 292
Self-citationMechanism of baricitinib supports artificial intelligence‐predicted testing in COVID ‐19 patients
Stebbing, J., Krishnan, V., de Bono, S., Ottaviani, S., Casalini, G., Richardson, P. J., Monteil, V., Lauschke, V. M., Mirazimi, A., Youhanna, S., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012697 · Cited by 291
Delirium in Older Patients With COVID-19 Presenting to the Emergency Department
Kennedy, M., Helfand, B. K. I., Gou, R. Y., Gartaganis, S. L., Webb, M., Moccia, J. M., Bruursema, S. N., Dokic, B., McCulloch, B., Ring, H., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.29540 · Cited by 290
Abani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)01825-0 · Cited by 290
Logue, S. E., McGrath, E. P., Cleary, P., Greene, S., Mnich, K., Almanza, A., Chevet, E., Dwyer, R. M., Oommen, A., Legembre, P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05763-8 · Cited by 283
Discovery and development of safe-in-man broad-spectrum antiviral agents
Andersen, P. I., Ianevski, A., Lysvand, H., Vitkauskiene, A., Oksenych, V., Bjørås, M., Telling, K., Lutsar, I., Dumpis, U., Irie, Y., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.02.018 · Cited by 280
Coronavirus infection, ER stress, apoptosis and innate immunity
Fung, T. S., & Liu, D. X. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00296 · Cited by 278
Fowlkes, A., Gaglani, M., Groover, K., Thiese, M. S., Tyner, H., Ellingson, K., & Cohorts, H.-R. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7034e4 · Cited by 271
Minakshi, R., Padhan, K., Rani, M., Khan, N., Ahmad, F., & Jameel, S. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008342 · Cited by 257
The COVID STEROID 2 Trial Group, Russell, L., Uhre, K. R., Lindgaard, A. L. S., Degn, J. F., Wetterslev, M., Sivapalan, P., Anthon, C. T., Mikkelsen, V. S., la Porta, L. C., et al. (2021) · JAMA · doi:10.1001/jama.2021.18295 · Cited by 253
Lescure, F.-X., Honda, H., Fowler, R. A., Lazar, J. S., Shi, G., Wung, P., Patel, N., Hagino, O., Bazzalo, I. J., Casas, M. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00099-0 · Cited by 246
Mehrbod, P., Ande, S. R., Alizadeh, J., Rahimizadeh, S., Shariati, A., Malek, H., Hashemi, M., Glover, K. K. M., Sher, A. A., Coombs, K. M., et al. (2019) · Virulence · doi:10.1080/21505594.2019.1605803 · Cited by 242
Self-citationJaniaud, P., Axfors, C., Schmitt, A. M., Gloy, V., Ebrahimi, F., Hepprich, M., Smith, E. R., Haber, N. A., Khanna, N., Moher, D., et al. (2021) · JAMA · doi:10.1001/jama.2021.2747 · Cited by 239
Dexamethasone for the Treatment of Coronavirus Disease (COVID-19): a Review
Ahmed, M. H., & Hassan, A. (2020) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-020-00610-8 · Cited by 234
Maeshima, K., Yamaoka, K., Kubo, S., Nakano, K., Iwata, S., Saito, K., Ohishi, M., Miyahara, H., Tanaka, S., Ishii, K., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34329 · Cited by 233
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
Shroff, R. T., Chalasani, P., Wei, R., Pennington, D., Quirk, G., Schoenle, M. V., Peyton, K. L., Uhrlaub, J. L., Ripperger, T. J., Jergović, M., et al. (2021) · Nature Medicine · doi:10.1038/s41591-021-01542-z · Cited by 233
Niclosamide Is a Proton Carrier and Targets Acidic Endosomes with Broad Antiviral Effects
Jurgeit, A., McDowell, R., Moese, S., Meldrum, E., Schwendener, R., & Greber, U. F. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002976 · Cited by 231
Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia
Giustino, G., Pinney, S. P., Lala, A., Reddy, V. Y., Johnston-Cox, H. A., Mechanick, J. I., Halperin, J. L., & Fuster, V. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.059 · Cited by 230
Long‐COVID syndrome‐associated brain fog and chemofog: Luteolin to the rescue
Theoharides, T. C., Cholevas, C., Polyzoidis, K., & Politis, A. (2021) · BioFactors · doi:10.1002/biof.1726 · Cited by 216
Tocilizumab: The first interleukin-6-receptor inhibitor
Sebba, A. (2008) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp070449 · Cited by 214
Sakr, Y., Giovini, M., Leone, M., Pizzilli, G., Kortgen, A., Bauer, M., Tonetti, T., Duclos, G., Zieleskiewicz, L., Buschbeck, S., et al. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-00741-0 · Cited by 211
Neurological manifestations of COVID-19: a systematic review and meta-analysis of proportions
Favas, T. T., Dev, P., Chaurasia, R. N., Chakravarty, K., Mishra, R., Joshi, D., Mishra, V. N., Kumar, A., Singh, V. K., Pandey, M., et al. (2020) · Neurological Sciences · doi:10.1007/s10072-020-04801-y · Cited by 211
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
Korley, F. K., Durkalski-Mauldin, V., Yeatts, S. D., Schulman, K., Davenport, R. D., Dumont, L. J., El Kassar, N., Foster, L. D., Hah, J. M., Jaiswal, S., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2103784 · Cited by 207
Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies
Singh, A. K., Singh, A., Singh, R., & Misra, A. (2020) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2020.05.018 · Cited by 197
Myocarditis in Clinical Practice
Sinagra, G., Anzini, M., Pereira, N. L., Bussani, R., Finocchiaro, G., Bartunek, J., & Merlo, M. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.05.013 · Cited by 196
Evolution patterns of SARS-CoV-2: Snapshot on its genome variants
Giovanetti, M., Benedetti, F., Campisi, G., Ciccozzi, A., Fabris, S., Ceccarelli, G., Tambone, V., Caruso, A., Angeletti, S., Zella, D., et al. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.10.102 · Cited by 192
COVID-19: The Potential Treatment of Pulmonary Fibrosis Associated with SARS-CoV-2 Infection
Lechowicz, K., Drożdżal, S., Machaj, F., Rosik, J., Szostak, B., Zegan-Barańska, M., Biernawska, J., Dabrowski, W., Rotter, I., & Kotfis, K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061917 · Cited by 184
Self-citationFDA approved drugs with pharmacotherapeutic potential for SARS-CoV-2 (COVID-19) therapy
Drożdżal, S., Rosik, J., Lechowicz, K., Machaj, F., Kotfis, K., Ghavami, S., & Łos, M. J. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100719 · Cited by 182
Self-citationBeneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
Cantini, F., Niccoli, L., Nannini, C., Matarrese, D., Natale, M. E. D., Lotti, P., Aquilini, D., Landini, G., Cimolato, B., Pietro, M. A. D., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.06.052 · Cited by 174
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19
Kreuzberger, N., Hirsch, C., Chai, K. L., Tomlinson, E., Khosravi, Z., Popp, M., Neidhardt, M., Piechotta, V., Salomon, S., Valk, S. J., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013825.pub2 · Cited by 169
Unfolded protein response (UPR) integrated signaling networks determine cell fate during hypoxia
Bartoszewska, S., & Collawn, J. F. (2020) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-020-00212-1 · Cited by 166
Does coronavirus affect the audio-vestibular system? A rapid systematic review
Almufarrij, I., Uus, K., & Munro, K. J. (2020) · International Journal of Audiology · doi:10.1080/14992027.2020.1776406 · Cited by 166
Kyriazopoulou, E., Huet, T., Cavalli, G., Gori, A., Kyprianou, M., Pickkers, P., Eugen-Olsen, J., Clerici, M., Veas, F., Chatellier, G., et al. (2021) · The Lancet Rheumatology · doi:10.1016/s2665-9913(21)00216-2 · Cited by 162
Pleiotropic effects of statins: A focus on cancer
Ahmadi, M., Amiri, S., Pecic, S., Machaj, F., Rosik, J., Łos, M. J., Alizadeh, J., Mahdian, R., da Silva Rosa, S. C., Schaafsma, D., et al. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165968 · Cited by 159
Self-citationAscorbate prevents microvascular dysfunction in the skeletal muscle of the septic rat
Armour, J., Tyml, K., Lidington, D., & Wilson, J. X. (2001) · Journal of Applied Physiology · doi:10.1152/jappl.2001.90.3.795 · Cited by 138
Fung, T. S., Huang, M., & Liu, D. X. (2014) · Virus Research · doi:10.1016/j.virusres.2014.09.016 · Cited by 136
Niclosamide, a Drug with Many (Re)purposes
Kadri, H., Lambourne, O. A., & Mehellou, Y. (2018) · ChemMedChem · doi:10.1002/cmdc.201800100 · Cited by 131
Okumuş, N., Demirtürk, N., Çetinkaya, R. A., Güner, R., Avcı, İ. Y., Orhan, S., Konya, P. Ş., Şaylan, B., Karalezli, A., Yamanel, L., et al. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-06104-9 · Cited by 131
Malgie, J., Schoones, J. W., & Pijls, B. G. C. W. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1445 · Cited by 127
Statins: Could an old friend help in the fight against COVID‐19?
Rodrigues-Díez, R. R., Tejera‐Muñoz, A., Márquez‐Expósito, L., Rayego‐Mateos, S., Santos‐Sanchez, L., Marchant, V. A., Tejedor-Santamaria, L., Ramos, A. M., Ortíz, A., Egido, J., et al. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15166 · Cited by 121
Prophylaxis against covid-19: living systematic review and network meta-analysis
Bartoszko, J. J., Siemieniuk, R. A., Kum, E., Qasim, A., Zeraatkar, D., Martinez, J. P. D., Azab, M., Ibrahim, S., Izcovich, A., Soto, G. B., et al. (2021) · BMJ · doi:10.1136/bmj.n949 · Cited by 113
Autophagy and SARS-CoV-2 infection: A possible smart targeting of the autophagy pathway
Shojaei, S., Suresh, M., Klionsky, D. J., Labouta, H. I., & Ghavami, S. (2020) · Virulence · doi:10.1080/21505594.2020.1780088 · Cited by 103
Self-citationArtese, A., Svicher, V., Costa, G., Salpini, R., Maio, V. C. D., Alkhatib, M., Ambrosio, F. A., Santoro, M. M., Assaraf, Y. G., Alcaro, S., et al. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100721 · Cited by 103
“Vitamin D supplementation and COVID-19 treatment: A systematic review and meta-analysis”
Rawat, D., Roy, A., Maitra, S., Shankar, V., Khanna, P., & Baidya, D. K. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102189 · Cited by 100
Ravikirti, Roy, R., Pattadar, C., Raj, R., Agarwal, N., Biswas, B., Manjhi, P. K., Kumar, D., Shyama, S., Kumar, A., et al. (2021) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/jpps32105 · Cited by 98
Neurocovid: Pharmacological Recommendations for Delirium Associated With COVID-19
Baller, E. B., Hogan, C. S., Fusunyan, M. A., Ivkovic, A., Luccarelli, J., Madva, E. N., Nisavic, M., Praschan, N. C., Quijije, N. V., Beach, S. R., et al. (2020) · Psychosomatics · doi:10.1016/j.psym.2020.05.013 · Cited by 97
Gao, D., Xu, M., Wang, G., Lv, J., Ma, X., Guo, Y., Zhang, D., Yang, H., Jiang, W., Deng, F., et al. (2021) · Aging · doi:10.18632/aging.202557 · Cited by 92
Regulation of Stress Responses and Translational Control by Coronavirus
Fung, T. S., Liao, Y., & Liu, D. X. (2016) · Viruses · doi:10.3390/v8070184 · Cited by 89
Al‐Khawaga, S., & Abdelalim, E. M. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-01963-6 · Cited by 85
Wang, L., & Song, Y. (2017) · The Clinical Respiratory Journal · doi:10.1111/crj.12646 · Cited by 84
Samaranayake, L. P., Fakhruddin, K. S., & Panduwawala, C. (2020) · Acta Odontologica Scandinavica · doi:10.1080/00016357.2020.1787505 · Cited by 83
Cheng, L.-L., Guan, W., Duan, C.-Y., Zhang, N.-F., Lei, C., Hu, Y., Chen, A.-L., Li, S.-Y., Zhuo, C., Deng, X.-L., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.5503 · Cited by 80
Snow, T. A. C., Saleem, N., Ambler, G., Nastouli, E., Singer, M., & Arulkumaran, N. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06416-z · Cited by 76
Fung, T. S., & Liu, D. X. (2019) · Virology · doi:10.1016/j.virol.2019.05.002 · Cited by 75
Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19)
Ray, S., Mukherjee Jagat, J., & Gangopadhyay, K. K. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.07.011 · Cited by 72
Dong, Z.-Y., Xiang, B., Jiang, M., Sun, M.-J., & Dai, C. (2020) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000001424 · Cited by 72
Zheng, F., Zhou, Y., Zhou, Z., Ye, F., Huang, B., Huang, Y., Ma, J., Zuo, Q., Tan, X., Xie, J., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.07.053 · Cited by 70
Wang, M. E., Zhao, Y., Hu, W., Zhao, D., Zhang, Y., Wang, T., Zheng, Z., Li, X., Zeng, S., Liu, Z., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1417 · Cited by 70
Angamo, M. T., Mohammed, M. A., & Peterson, G. M. (2021) · Infection · doi:10.1007/s15010-021-01671-0 · Cited by 70
Endoplasmic reticulum as a potential therapeutic target for covid-19 infection management?
Sureda, A., Alizadeh, J., Nabavi, S. F., Berindan‐Neagoe, I., Cismaru, C. A., Jeandet, P., Łoś, M., Clementi, E., Nabavi, S. M., & Ghavami, S. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173288 · Cited by 67
Self-citationColchicine and SARS-CoV-2: Management of the hyperinflammatory state
Vitiello, A., & Ferrara, F. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2021.106322 · Cited by 65
Plausible mechanisms of Niclosamide as an antiviral agent against COVID-19
Pindiprolu, S. K. S. S., & Pindiprolu, S. H. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109765 · Cited by 64
İdilman, İ. S., Dizman, G. T., Düzgün, S. A., Irmak, İ., Karçaaltıncaba, M., İnkaya, A. Ç., Demirkazık, F., Durhan, G., Akpınar, M. G., Arıyürek, O. M., et al. (2020) · European Radiology · doi:10.1007/s00330-020-07155-3 · Cited by 63
COVID-19 update: The race to therapeutic development
Twomey, J. D., Luo, S., Dean, A. Q., Bozza, W. P., Nalli, A. D., & Zhang, B. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100733 · Cited by 62
Boosting immunity to COVID-19 vaccines
Juno, J. A., & Wheatley, A. K. (2021) · Nature Medicine · doi:10.1038/s41591-021-01560-x · Cited by 61
Amantadine Inhibits SARS-CoV-2 In Vitro
Fink, K., Nitsche, A., Neumann, M., Grossegesse, M., Eisele, K., & Danysz, W. (2021) · Viruses · doi:10.3390/v13040539 · Cited by 60
Statins in patients with COVID-19: a retrospective cohort study in Iranian COVID-19 patients
Peymani, P., Dehesh, T., Aligolighasemabadi, F., Sadeghdoust, M., Kotfis, K., Ahmadi, M., Mehrbod, P., Iranpour, P., Dastghaib, S., Nasimian, A., et al. (2021) · Translational Medicine Communications · doi:10.1186/s41231-021-00082-5 · Cited by 59
Self-citationEffects of Aspirin on Endothelial Function and Hypertension
Dzeshka, M. S., Shantsila, A., & Lip, G. Y. H. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0688-8 · Cited by 47
Potential antidepressant effect of amantadine: a review of preclinical studies and clinical trials
Raupp, I. M., Vital, M. A. B. F., Galduróz, J. C. F., & Andreatini, R. (2018) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2017-2393 · Cited by 44
Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis
Bansal, V., Mahapure, K. S., Mehra, I., Bhurwal, A., Tekin, A., Singh, R., Gupta, I., Rathore, S. S., Khan, H., Deshpande, S., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.624924 · Cited by 44
Antibody Persistence 6 Months Post-Vaccination with BNT162b2 among Health Care Workers
Campo, F., Venuti, A., Pimpinelli, F., Abril, E., Blandino, G., Conti, L., VIRGILIO, A. D., Marco, F. D., Noia, V. D., Domenico, E. G. D., et al. (2021) · Vaccines · doi:10.3390/vaccines9101125 · Cited by 44
COVID-19—The Potential Beneficial Therapeutic Effects of Spironolactone during SARS-CoV-2 Infection
Kotfis, K., Lechowicz, K., Drożdżal, S., Niedźwiedzka‐Rystwej, P., Wojdacz, T. K., Grywalska, E., Biernawska, J., Wiśniewska, M., & Parczewski, M. (2021) · Pharmaceuticals · doi:10.3390/ph14010071 · Cited by 43
Self-citationCobos-Siles, M. M., Cubero-Moráis, P., Jiménez, I. A., Rey-Hernández, M., Hernández-Gómez, L., Vargas-Parra, D. J., González-Fernández, M., González, M. C., Gabella-Martín, M., Albi, T. R., et al. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02485-y · Cited by 42
Observational study of people infected with SARS-Cov-2, treated with amantadine
Aranda-Abreu, G. E., Aranda‐Martínez, J. D., Araújo, R., Hernández‐Aguilar, M. E., Herrera‐Covarrubias, D., & Rojas-Durán, F. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00168-1 · Cited by 40
Pawlowski, C., Venkatakrishnan, A., Kirkup, C., Berner, G., Puranik, A., O’Horo, J. C., Badley, A. D., & Soundararajan, V. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100774 · Cited by 40
Abdulamir, A. S., Gorial, F. I., Saadi, S. J., Maulood, M. F., Hashim, H. A., Alnuaimi, A. S., & abdulrrazaq, M. K. (2021) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2021.102779 · Cited by 39
Diaz‐Arocutipa, C., Brañez‐Condorena, A., & Hernández, A. V. (2021) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.5234 · Cited by 38
Amani, B., Khanijahani, A., & Amani, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-91089-3 · Cited by 36
Sinner, B. (2019) · Der Anaesthesist · doi:10.1007/s00101-019-00672-x · Cited by 36
Rationales and uncertainties for aspirin use in COVID-19: a narrative review
Ahmed, H. A. S., Merrell, E., Ismail, M., Joudeh, A. I., Riley, J. B., Shawkat, A., Habeb, H., Darling, E., Goweda, R. A., Shehata, M. H., et al. (2021) · Family Medicine and Community Health · doi:10.1136/fmch-2020-000741 · Cited by 35
Golpour, M., Mousavi, T., Alimohammadi, M., Mosayebian, A., Shiran, M., Alizadeh‐Navaei, R., & Rafiei, A. (2021) · International Journal of Immunopathology and Pharmacology · doi:10.1177/20587384211031763 · Cited by 34
Yue, L., Zhou, J., Zhou, Y., Yang, X., Xie, T., Yang, M., Zhao, H., Zhao, Y., Yang, T., Li, H., et al. (2021) · Emerging Microbes & Infections · doi:10.1080/22221751.2021.1996210 · Cited by 31
Geriak, M., Haddad, F. A., Kullar, R., Greenwood, K. L., Habib, M., Habib, C., Willms, D. C., & Sakoulas, G. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00453-3 · Cited by 29
Should we supplement zinc in COVID-19 patients? Evidence from meta-analysis
Szarpak, Ł., Pruc, M., Gąsecka, A., Jaguszewski, M. J., Michalski, T. A., Peacock, F. W., Smereka, J., Pytkowska, K., & Filipiak, K. J. (2021) · Polskie Archiwum Medycyny Wewnętrznej · doi:10.20452/pamw.16048 · Cited by 29
Zein, A. F. M., Sulistiyana, C. S., Raffaelo, W., et al. (2021) · Diabetes & Metabolic syndrome: clinical Research & Reviews · doi:10.1016/j.dsx.2021.102186 · Cited by 29
Aviani, J. K., Halim, D., Soeroto, A. Y., Achmad, T. H., & Djuwantono, T. (2021) · Reviews in Medical Virology · doi:10.1002/rmv.2225 · Cited by 28
Protective role of ascorbic acid against lipid peroxidation and myocardial injury
Chakrabarty, S., Nandi, A., Mukhopadhyay, C., & Chatterjee, I. B. (1992) · Molecular and Cellular Biochemistry · doi:10.1007/bf00229572 · Cited by 27
Autophagy: The Potential Link between SARS-CoV-2 and Cancer
Habibzadeh, P., Dastsooz, H., Eshraghi, M., Łoś, M., Klionsky, D. J., & Ghavami, S. (2021) · Cancers · doi:10.3390/cancers13225721 · Cited by 26
Self-citationTanasescu, S., Levesque, H., & Thuillez, C. (2000) · La Revue de Médecine Interne · doi:10.1016/s0248-8663(00)88721-4 · Cited by 21
Estatinas en COVID-19: ¿existe algún fundamento?
Martínez, M. M. L., Contreras, M. A., Marín, W., & D’Marco, L. (2020) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2020.06.003 · Cited by 21
High-dose vitamin C intravenous infusion in the treatment of patients with COVID-19
Huang, L., Wang, L., Tan, J., Liu, H., & Ni, Y. (2021) · Medicine · doi:10.1097/md.0000000000025876 · Cited by 21
Renal artery thrombosis in COVID-19
Acharya, S., Anwar, S., Siddiqui, F. S., Shabih, S., Manchandani, U. K., & Dalezman, S. (2020) · IDCases · doi:10.1016/j.idcr.2020.e00968 · Cited by 18
Efficacy and Safety of Convalescent Plasma for COVID-19: A Systematic Review and Meta-analysis
Prasad, M., Seth, T., & Elavarasi, A. (2021) · Indian Journal of Hematology and Blood Transfusion · doi:10.1007/s12288-021-01417-w · Cited by 18
Brunaugh, A. D., Seo, H., Warnken, Z. N., Ding, L., Seo, S. H., & Smyth, H. D. C. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.24.310490 · Cited by 17
Bellos, I. (2021) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2021.03.020 · Cited by 13
Kashour, Z., Kashour, T. S., Gerberi, D., et al. (2021) · Clinical and Translational Science · doi:10.1111/cts.13001 · Cited by 10
Maxingshigan decoction for treating COVID-19: A protocol for systematic review and meta analysis
Shao, G., Huang, S., Cui, Y., & Yang, D. (2020) · Medicine · doi:10.1097/md.0000000000023224 · Cited by 6
Efficacy and safety of Lianhua Qingwen in the treatment of patients with moderate COVID-19 infection
Liu, N., Zhang, T., Ma, L., et al. (2020) · Medicine · doi:10.1097/md.0000000000021614 · Cited by 4
Traditional Chinese medicine formula Xiaoqinglong decoction for cough caused by COVID-19
Ren, X., Shi, Y., & Li, G. (2020) · Medicine · doi:10.1097/md.0000000000023261 · Cited by 2
Cited by
Najjar-Debbiny, R., Gronich, N., Weber, G., Khoury, J., Amar, M., Stein, N., Goldstein, L. H., & Saliba, W. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciac443 · Cited by 521
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies
Cox, M., Peacock, T. P., Harvey, W. T., Hughes, J., Wright, D. W., COVID-19 Genomics UK (COG-UK) Consortium, Willett, B. J., Thomson, E., Gupta, R. K., Peacock, S. J., et al. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00809-7 · Cited by 344
Metadata
- Authors
- Drożdżal, S., Rosik, J., Lechowicz, K., Machaj, F., Szostak, B., Przybyciński, J., Lorzadeh, S., Kotfis, K., Ghavami, S., & Łos, M. J.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2021-12
- Volume
- 59
- Pages
- 100794
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W4200113990
- Cited by
- 286
- References
- 161
- FWCI
- 18.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.